OGI Latest Quotes, Charts & Stock Information

Home » OGI

Latest Insights on OGI

The Yield Curve Holds the Secret to the Market’s Health September 27, 2018 by Ian King Stocks On Wednesday, the Federal Reserve raised short-term interest rates by a quarter point and signaled yet another quarter-point hike before the end of the year. Notably, this is the first time the Fed funds rate — currently at 2.00% to 2.25% — has risen above the rate of inflation. The Fed’s preferred metric for inflation […]

But unlike the pre-financial crisis era (stoked largely by brokers and lenders content to look the other way), today’s mortgage fraud comes with a twist.

New Mortgage Fraud Echoes the 2008 Financial Crisis – But We Are Prepared September 25, 2018 by Jeff Yastine Real Estate But unlike the pre-financial crisis era (stoked largely by brokers and lenders content to look the other way), today’s mortgage fraud comes with a twist.

If you want to know of a massive tech trend that will be sure to mint millionaires over the coming year, robotics is your answer.

This Massive Tech Trend Is Set for Explosive Growth September 22, 2018 by Jessica Cohn Technology If you want to know of a massive tech trend that will be sure to mint millionaires over the coming year, this is your answer.

Hurricane season is upon us. So is the trepidation that folks in the way of these storms feel. That said, these terrible events can also bring opportunity.

Natural Disasters Create Opportunities for Investors September 19, 2018 by Brian Christopher Investment Opportunities Hurricane season is upon us. So is the trepidation that folks in the way of these storms feel. That said, these terrible events can also bring opportunity.

The amount of new clinical trials is increasing exponentially. This gives constant opportunities to profit from biotech companies releasing results.

Biotech Has More Opportunities Than Ever Before September 19, 2018 by Ian Dyer Investment Opportunities The amount of new clinical trials is increasing exponentially. This gives constant opportunities to profit from biotech companies releasing results.